268 related articles for article (PubMed ID: 15766869)
1. Expression, purification, and characterization of Leishmania donovani trypanothione reductase in Escherichia coli.
Mittal MK; Misra S; Owais M; Goyal N
Protein Expr Purif; 2005 Apr; 40(2):279-86. PubMed ID: 15766869
[TBL] [Abstract][Full Text] [Related]
2. Glutathione reductase turned into trypanothione reductase: structural analysis of an engineered change in substrate specificity.
Stoll VS; Simpson SJ; Krauth-Siegel RL; Walsh CT; Pai EF
Biochemistry; 1997 May; 36(21):6437-47. PubMed ID: 9174360
[TBL] [Abstract][Full Text] [Related]
3. The parasite-specific trypanothione metabolism of trypanosoma and leishmania.
Krauth-Siegel RL; Meiering SK; Schmidt H
Biol Chem; 2003 Apr; 384(4):539-49. PubMed ID: 12751784
[TBL] [Abstract][Full Text] [Related]
4. Cloning and expression of trypanothione reductase from a New World Leishmania species.
Castro-Pinto DB; Genestra M; Menezes GB; Waghabi M; Gonçalves A; De Nigris Del Cistia C; Sant'Anna CM; Leon LL; Mendonça-Lima L
Arch Microbiol; 2008 Apr; 189(4):375-84. PubMed ID: 18060667
[TBL] [Abstract][Full Text] [Related]
5. A glutathione-specific aldose reductase of Leishmania donovani and its potential implications for methylglyoxal detoxification pathway.
Rath J; Gowri VS; Chauhan SC; Padmanabhan PK; Srinivasan N; Madhubala R
Gene; 2009 Jan; 429(1-2):1-9. PubMed ID: 18983902
[TBL] [Abstract][Full Text] [Related]
6. Trypanothione reductase from the human parasite Entamoeba histolytica: a new drug target.
Tamayo EM; Iturbe A; Hernández E; Hurtado G; de Lourdes Gutiérrez-X M; Rosales JL; Woolery M; Ondarza RN
Biotechnol Appl Biochem; 2005 Apr; 41(Pt 2):105-15. PubMed ID: 15157186
[TBL] [Abstract][Full Text] [Related]
7. Trypanothione biosynthesis in Leishmania major.
Oza SL; Shaw MP; Wyllie S; Fairlamb AH
Mol Biochem Parasitol; 2005 Jan; 139(1):107-16. PubMed ID: 15610825
[TBL] [Abstract][Full Text] [Related]
8. Cloning, expression, characterization and inhibition studies on trypanothione synthetase, a drug target enzyme, from Leishmania donovani.
Saudagar P; Dubey VK
Biol Chem; 2011 Dec; 392(12):1113-22. PubMed ID: 22050226
[TBL] [Abstract][Full Text] [Related]
9. Glyoxalase I from Leishmania donovani: a potential target for anti-parasite drug.
Padmanabhan PK; Mukherjee A; Singh S; Chattopadhyaya S; Gowri VS; Myler PJ; Srinivasan N; Madhubala R
Biochem Biophys Res Commun; 2005 Dec; 337(4):1237-48. PubMed ID: 16236261
[TBL] [Abstract][Full Text] [Related]
10. Molecular basis of antimony treatment in leishmaniasis.
Baiocco P; Colotti G; Franceschini S; Ilari A
J Med Chem; 2009 Apr; 52(8):2603-12. PubMed ID: 19317451
[TBL] [Abstract][Full Text] [Related]
11. Trypanothione reductase from Leishmania donovani. Purification, characterisation and inhibition by trivalent antimonials.
Cunningham ML; Fairlamb AH
Eur J Biochem; 1995 Jun; 230(2):460-8. PubMed ID: 7607216
[TBL] [Abstract][Full Text] [Related]
12. Characterization of the gene encoding glyoxalase II from Leishmania donovani: a potential target for anti-parasite drugs.
Padmanabhan PK; Mukherjee A; Madhubala R
Biochem J; 2006 Jan; 393(Pt 1):227-34. PubMed ID: 16159313
[TBL] [Abstract][Full Text] [Related]
13. Down-regulation of Leishmania donovani trypanothione reductase by heterologous expression of a trans-dominant mutant homologue: effect on parasite intracellular survival.
Tovar J; Cunningham ML; Smith AC; Croft SL; Fairlamb AH
Proc Natl Acad Sci U S A; 1998 Apr; 95(9):5311-6. PubMed ID: 9560272
[TBL] [Abstract][Full Text] [Related]
14. Structure-guided approach to identify a novel class of anti-leishmaniasis diaryl sulfide compounds targeting the trypanothione metabolism.
Colotti G; Saccoliti F; Gramiccia M; Di Muccio T; Prakash J; Yadav S; Dubey VK; Vistoli G; Battista T; Mocci S; Fiorillo A; Bibi A; Madia VN; Messore A; Costi R; Di Santo R; Ilari A
Amino Acids; 2020 Feb; 52(2):247-259. PubMed ID: 31037461
[TBL] [Abstract][Full Text] [Related]
15. Redox enzyme engineering: conversion of human glutathione reductase into a trypanothione reductase.
Bradley M; Bücheler US; Walsh CT
Biochemistry; 1991 Jun; 30(25):6124-7. PubMed ID: 2059620
[TBL] [Abstract][Full Text] [Related]
16. The structure, organization, and expression of the Leishmania donovani gene encoding trypanothione reductase.
Taylor MC; Kelly JM; Chapman CJ; Fairlamb AH; Miles MA
Mol Biochem Parasitol; 1994 Apr; 64(2):293-301. PubMed ID: 7935607
[TBL] [Abstract][Full Text] [Related]
17. Polyamine metabolism in Leishmania: from arginine to trypanothione.
Colotti G; Ilari A
Amino Acids; 2011 Feb; 40(2):269-85. PubMed ID: 20512387
[TBL] [Abstract][Full Text] [Related]
18. Characterization of recombinant glutathionylspermidine synthetase/amidase from Crithidia fasciculata.
Oza SL; Ariyanayagam MR; Fairlamb AH
Biochem J; 2002 Jun; 364(Pt 3):679-86. PubMed ID: 12049631
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and evaluation of substrate analogue inhibitors of trypanothione reductase.
Duyzend MH; Clark CT; Simmons SL; Johnson WB; Larson AM; Leconte AM; Wills AW; Ginder-Vogel M; Wilhelm AK; Czechowicz JA; Alberg DG
J Enzyme Inhib Med Chem; 2012 Dec; 27(6):784-94. PubMed ID: 22085139
[TBL] [Abstract][Full Text] [Related]
20. Engineering the substrate specificity of glutathione reductase toward that of trypanothione reduction.
Henderson GB; Murgolo NJ; Kuriyan J; Osapay K; Kominos D; Berry A; Scrutton NS; Hinchliffe NW; Perham RN; Cerami A
Proc Natl Acad Sci U S A; 1991 Oct; 88(19):8769-73. PubMed ID: 1924337
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
